Stephen A. Byeff
Mr. Byeff is an associate in Davis Polk's Corporate Department, practicing in the Capital Markets Group. His practice includes advising U.S. and non-U.S. clients across a variety of industries on capital markets transactions, including initial public offerings and other equity offerings and public and private high-yield, investment-grade and convertible debt offerings. He also advises clients on governance, corporate and securities law matters. His practice ranges across a variety of industries, including consumer, retail, food and beverage, technology, industrials, biotech, pharmaceuticals and financial services.
CAPITAL MARKETS TRANSACTIONS
- IPOs for Collier Creek Holdings, Hudson Ltd., Dova Pharmaceuticals and Mersana Therapeutics
- Equity offerings for International Flavors & Fragrances, RealPage, General Mills and XPO
- Investment grade and high-yield debt offerings (including in connection with acquisition financings) for Bausch Health Companies, Brookfield Business Partners, General Mills, Discovery Communications, International Flavors & Fragrances, The Bank of N.T. Butterfield & Son, GeoPark Limited and Textron
- Public reporting, securities compliance and corporate governance advice for a variety of large, mid and small cap companies, including Bausch Health Companies, Hudson Ltd., Verisk Analytics and Clarios Power Solutions
- Davis Polk since 2015